Login to Your Account

Biotech Product Development: ’97 Product Blow-Ups Worse Spate Of Failures In Three Years

Monday, February 23, 1998
By Jennifer Van Brunt



There are literally hundreds of biotechnology drugs in clinical development today. Estimates range all over the place, but with about 300 products in late-stage development (i.e., Phase II/III or Phase III trials), it's possible that there could be at least twice or even thrice that many in earlier development stages.


To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription